A new study published in US Endocrinology found Abbott’s continuous glucose monitoring system, the FreeStyle Libre, demonstrated significant cost savings for diabetic care compared to traditional ...

The study found that HbA1c which is an average measurement of blood glucose levels over 90 days didn’t increase compared to the finger-stick group. Abbott interpreted that result as a sign that the ...

When the FDA approved Abbott’s FreeStyle Libre Flash continuous glucose monitoring (CGM) system in September 2017, diabetes advocates hailed the move as long overdue and one that might lead to greater ...

This morning Abbott revealed that its much anticipated integrated continuous glucose monitoring system the FreeStyle Libre 2 is now FDA cleared for adults and kids over the age of 4 with diabetes. The ...

In a recent press release from Abbott, they announced FreeStyle® Libre System, the company’s revolutionary new continuous glucose monitoring (CGM) system, is now available to Medicare patients, having ...

"FreeStyle Libre technology was designed from the start to be affordable and accessible," said Jared Watkin, senior vice president for Abbott's diabetes care business. "We've been focused on ...

Abbott's FreeStyle Libre Flash glucose monitoring system--Courtesy of Abbott Abbott ($ABT) reported the latest data for its FreeStyle Libre system that doesn't ...

SAN FRANCISCO – Fingerstick-free continuous glucose monitors (CGMs) are a fast-growing segment, where Abbott has a first mover advantage. Dexcom Inc., of San Diego, gained its own label last year on ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Abbott issued a medical device correction for some ...

The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that can be used by adult patients to make ...